Figure 7

Tumor-targeting rates of IR780-NBs-DTX, IR-780 iodide and NBs(FITC) evaluated via FCM analysis after incubation with Mia-Paca2 pancreatic cancer cells.

Tumor-targeting rates of IR780-NBs-DTX, IR-780 iodide and NBs(FITC) evaluated via FCM analysis after incubation with Mia-Paca2 pancreatic cancer cells.